Position in RXRX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$72,683,498
-$24,556,136 QoQ
Shares Held
23,675,407
-0.4% QoQ
Ownership
4.47%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAILLIE GIFFORD & CO holds $3,167,080,960 across 13 Biotechnology names. RXRX ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
19,985,876 | $1,015,282,499 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,493,866 | $825,145,441 | |
| 3 | RPRX |
Royalty Pharma plc
|
16,155,677 | $774,987,824 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
12,066,479 | $231,676,395 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,421 | $89,049,452 | |
| 6 | BNTX |
BioNTech SE
|
882,572 | $78,442,998 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
23,675,407 | $72,683,498 | |
| 8 | SANA |
Sana Biotechnology, Inc.
|
6,609,065 | $19,034,107 |
All Filings in RXRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $72,683,498 | 23,675,407 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $97,239,634 | 23,774,972 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $117,016,030 | 23,978,695 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $122,319,502 | 24,173,815 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $129,039,047 | 24,393,015 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $168,081,031 | 24,864,058 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $166,330,741 | 25,239,870 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $199,424,519 | 26,589,936 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $239,956,004 | 24,067,804 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $238,409,907 | 24,179,504 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $187,818,276 | 24,551,409 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $187,479,294 | 25,097,630 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $167,653,983 | 25,135,530 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $191,368,751 | 24,820,850 | Shares | Defined | 2023-03-10 | |
| 2022-09-30 | $229,767,531 | 21,594,693 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $175,870,274 | 21,605,685 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $157,388,283 | 21,981,604 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $378,969,644 | 22,123,155 | Shares | Defined | 2022-01-20 | |
| 2021-09-30 | $507,632,213 | 22,061,374 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $676,016,498 | 18,521,000 | Shares | Defined | 2021-08-02 | |
| No filing history on record for this holder in this stock. | ||||||